Healthcare Analytical Testing Services Market Outlook Signals Expansion To $14.64 Billion Through 2030

The healthcare sector is rapidly evolving, and one area gaining significant attention is healthcare analytical testing services. As advancements in technology and personalized medicine accelerate, this market is positioned for substantial growth. Below, we explore the market's projected expansion, influential companies, emerging trends, and detailed segment breakdowns to offer a comprehensive view of its future trajectory.

Forecasted Market Size for Healthcare Analytical Testing Services by 2030
The healthcare analytical testing services market is projected to expand swiftly, reaching a value of $14.64 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 13.9%. Key factors propelling this surge include the increasing use of AI-driven lab analytics, heightened demand for high-throughput testing, the rise of personalized medicine, a stronger emphasis on rapid microbial detection, and a growing trend of outsourcing analytical validation tasks. Anticipated trends during this period also involve greater adoption of advanced bioanalytical testing, the shift toward automated laboratory systems, a focus on validation services meeting regulatory standards, expanded outsourced testing, and deeper integration of digital lab platforms.

The healthcare analytical testing services market size has grown rapidly in recent years. It will grow from $7.6 billion in 2025 to $8.7 billion in 2026 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to increasing pharmaceutical r&d activities, rising complexity of biologic drugs, expansion of contract research services, growing regulatory testing requirements, increased focus on quality assurance.

Download a free sample of the healthcare analytical testing services market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7448&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Prominent Companies Leading the Healthcare Analytical Testing Services Market
The competitive landscape of the healthcare analytical testing services market features several significant players. Notable among these are Almac Group, ALS Limited, Anacura Life Sciences, Charles River Laboratories International Inc., Element Materials Technology Group, Eurofins Scientific SE, ICON plc, Impact Analytical Testing Lab, Intertek Group plc, Pace Analytical Services LLC, PPD Inc., SourceBio International plc, Steris Corporation, Syneos Health Inc., WuXi AppTec, Analytical Bio-Chemistry Laboratories, Avance Biosciences, Avista Pharma Solutions, Avomeen Analytical Services, BioPharma Services Inc., Boston Analytical, Laboratory Corporation, MedPharm Inc., Micro Quality Labs, Microbac Laboratories, Nelson Laboratories LLC, and Pacific Biolabs Inc.

Strategic Acquisitions Enhancing Market Capabilities
In a notable development in September 2024, US-based contract development and manufacturing organization Pace Life Sciences acquired Catalent Small Molecule Analytical services from Catalent. Although the financial details were not disclosed, this acquisition enables Pace to bolster its position as a comprehensive analytical outsourcing provider. The expanded capabilities particularly support clients throughout the continuum of drug research and development to commercialization. Catalent itself is a well-established US provider specializing in analytical services for drug development.

View the full healthcare analytical testing services market report:
https://www.thebusinessresearchcompany.com/report/healthcare-analytical-testing-services-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Upcoming Trends in Healthcare Analytical Testing Services Market
Leading firms in this market are concentrating on delivering innovative services that offer broad bioanalytical coverage. This means providing extensive support for drug development phases, from early discovery through late-stage clinical trials, including key pharmacokinetic (PK) and pharmacodynamic (PD) evaluations. Broad bioanalytical coverage reflects a laboratory's ability to perform a diverse array of tests across multiple molecule types and stages of drug development.

For example, in August 2024, SGS Life Science Services SA, a Swiss contract research organization specializing in analytical development and quality control, launched a new bioanalytical testing laboratory. This facility focuses on measuring drugs alongside their metabolites and other biologically relevant molecules in samples. It also offers cell-based assays for cellular biomarkers and provides highly sensitive quantification techniques.

Detailed Segment Breakdown of Healthcare Analytical Testing Services Market
This market can be examined through several key segments:

1) By Type:
- Bioanalytical Testing Services
- Physical Characterization Services
- Method Development and Validation Testing Services
- Raw Material Testing Services
- Batch-Release Testing Services
- Stability Testing
- Microbial Testing Services

2) By Application:
- Drug Discovery and Preclinical Research
- Clinical Trials (Phases I to III)
- Quality Control and Batch-Release Testing
- Stability Studies and Shelf-Life Characterization
- Regulatory Compliance and Submission Support
- Manufacturing Process Support and Troubleshooting
- Post-Market Surveillance and Pharmacovigilance Testing

3) By End User:
- Pharmaceutical and Biopharmaceutical Companies
- Medical Device Companies
- Contract Research Organizations

Further subcategories include:

- Bioanalytical Testing Services subdivided into Pharmacokinetics Testing and Biomarker Analysis.
- Physical Characterization Services covering Particle Size Analysis and Surface Area Analysis.
- Method Development and Validation including Analytical Method Development and Method Validation.
- Raw Material Testing encompassing Identity Testing and Purity Testing.
- Batch-Release Testing with Quality Control Testing and Compliance Testing.
- Stability Testing divided into Accelerated and Long-Term Stability Testing.
- Microbial Testing Services such as Sterility Testing and Endotoxin Testing.

This detailed segmentation provides a clear framework to understand the comprehensive nature of healthcare analytical testing services and their critical role across the drug development lifecycle.

Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.